Search
© 2013 Leibniz-Institut für Virologie

SARS-CoV-2 variants

Current data by the Hamburg Surveillance Platform

Last Update: 30.01.2023

Link to the website

HPI becomes LIV - Leibniz Institute of Virology

Relaunch with new name and logo on May 9, 2022
 
To the press release

The LIV

The institute's mission statement: „The LIV investigates the biology of human pathogenic viruses. It is our aim to unravel the molecular mechanisms that control viral life cycles and virus induced pathogenesis. This research will provide novel targets and therapeutic approaches for established and emerging viral diseases.“ Learn more about the LIV.

Coronavirus

 

SARS-CoV-2/COVID-19:

Current Information, Links & Adresses

 

 

Exterior view of the HPI building

News

13 October 2022: Dr Luca Bertzbach receives prize of the Annelise-und-Curt-Hoehner-Foundation 2022

Thursday, 13. October 2022

During the DVG Vet Congress, which took place as a hybrid format in Berlin and online, the prize of the Annelise-und-Curt-Höhner-Stiftung 2022 was awarded to LIV scientist Dr Luca Bertzbach.

[more]

September 19, 2022: LIV Strategy Retreat 2022

Monday, 19. September 2022

September 19, 2022: The Scientific Council of the LIV met for a joint strategy retreat

[more]

Press

LCI Symposium: Compartments in Infection

Friday, 20. January 2023

On January 26-27, 2023, international researchers will gather at the Bernhard Nocht Institute for Tropical Medicine to discuss the role of cellular compartments as niches for the survival of infectious agents in the body.

[more]

H7N9 avian influenza in humans: sex differences in disease outcome

Monday, 14. November 2022

New research shows that H7N9 infections attack the hormonal axis of males but not females

[more]

Seminars

no news in this list.